Table 1.
Baseline characteristics of patients in two cohorts.
| CPI N (%) |
No-CPI N (%) |
Overall | p-Value | ||
|---|---|---|---|---|---|
| No. of patients | 10 (33.3) | 20 (66.7) | 30 (100) | ||
| Age, years | Mean | 63 | 56 | 58.4 | 0.22 |
| Median | 61.5 | 58 | 59 | ||
| Age, years | ≤60 | 5 (50) | 11 (55) | 16 (53.3) | 1.00 |
| >60 | 5 (50) | 9 (45) | 14 (46.7) | ||
| Sex | Male | 7 (70) | 10 (50) | 17 (56.7) | 0.44 |
| Female | 3 (30) | 10 (50) | 13 (43.3) | ||
| Race | Caucasian | 9 (90) | 19 (95) | 28 (93.3) | 1.00 |
| African American | 1 (10) | 1 (5) | 2 (6.7) | ||
| Stage at diagnosis | 2 | 2 (20) | 2 (6.7) | 0.10 | |
| 3 | 4 (40) | 6 (30) | 10 (33.3) | ||
| 4 | 4 (40) | 14 (70) | 18 (60) | ||
| IMDC Risk Score | Low (0) | 1 (10) | 1 (5) | 2 | 0.31 |
| Intermediate (1-2) | 2 (20) | 9 (45) | 11 | ||
| Poor (≥3) | 7 (70) | 10 (50) | 17 | ||
CPI: Check point Inhibitors, IMDC: International Metastatic Renal Cell Carcinoma Database.